Cargando…
Expression Profiling in Ovarian Cancer Reveals Coordinated Regulation of BRCA1/2 and Homologous Recombination Genes
Predictive biomarkers are crucial in clarifying the best strategy to use poly(ADP-ribose) polymerase inhibitors (PARPi) for the greatest benefit to ovarian cancer patients. PARPi are specifically lethal to cancer cells that cannot repair DNA damage by homologous recombination (HR), and HR deficiency...
Autores principales: | Custódio, Noélia, Savisaar, Rosina, Carvalho, Célia, Bak-Gordon, Pedro, Ribeiro, Maria I., Tavares, Joana, Nunes, Paula B., Peixoto, Ana, Pinto, Carla, Escudeiro, Carla, Teixeira, Manuel R., Carmo-Fonseca, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868827/ https://www.ncbi.nlm.nih.gov/pubmed/35203410 http://dx.doi.org/10.3390/biomedicines10020199 |
Ejemplares similares
-
Gene Panel Tumor Testing in Ovarian Cancer Patients Significantly Increases the Yield of Clinically Actionable Germline Variants beyond BRCA1/BRCA2
por: Barbosa, Ana, et al.
Publicado: (2020) -
Computational prediction of human deep intronic variation
por: Barbosa, Pedro, et al.
Publicado: (2023) -
Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects
por: Peixoto, Ana, et al.
Publicado: (2020) -
BRCA2 and homologous recombination
por: Orelli, Brian J, et al.
Publicado: (2001) -
Transcription and splicing dynamics during early Drosophila development
por: Prudêncio, Pedro, et al.
Publicado: (2022)